Eva Marie Erfurth
61 – 70 of 120
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2005
-
Mark
The utility of the GHRH-arginine test for diagnosing GH deficiency in adults with childhood acute lymphoblastic leukemia (ALL) treated with cranial irradiation.
(
- Contribution to journal › Article
-
Mark
Epidemiology of adult growth hormone deficiency.
(
- Contribution to journal › Scientific review
-
Mark
Baseline characteristics and response to 2 years of growth hormone replacement of hypopituitary patients with growth hormone deficiency due to adult-onset craniopharyngioma in comparison to patients with non-functioning pituitary adenoma: data from KIMS (
(
- Contribution to journal › Article
-
Mark
Effects of different doses of adrenocorticotrophic hormone on the serum lipoprotein profile in healthy subjects
(
- Contribution to journal › Article
- 2004
-
Mark
Doubled mortality rate in irradiated patients reoperated for regrowth of a macroadenoma of the pituitary gland.
(
- Contribution to journal › Article
-
Mark
Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: Analysis of KIGS (Pfizer International Growth Database)
(
- Contribution to journal › Article
-
Mark
Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H)
(
- Contribution to journal › Article
-
Mark
Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood.
(
- Contribution to journal › Article
-
Mark
Is growth hormone deficiency contributing to heart failure in patients with beta-thalassemia major?
(
- Contribution to journal › Article
-
Mark
Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment.
(
- Contribution to journal › Article